+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Endometriosis Drug"

Endometriosis Drugs: Global Strategic Business Report - Product Thumbnail Image

Endometriosis Drugs: Global Strategic Business Report

  • Report
  • April 2024
  • 191 Pages
  • Global
From
From
Endometriosis - Pipeline Insight, 2024 - Product Thumbnail Image

Endometriosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Endometriosis Treatment Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Endometriosis Treatment Market - Forecasts from 2024 to 2029

  • Report
  • January 2024
  • 143 Pages
  • Global
From
Uterine Fibroids & Endometriosis - Pipeline Insight, 2024 - Product Thumbnail Image

Uterine Fibroids & Endometriosis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
US Endometriosis Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Endometriosis Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
From
From
From
Global Endometriosis Drugs Market 2021-2025 - Product Thumbnail Image

Global Endometriosis Drugs Market 2021-2025

  • Report
  • May 2021
  • 120 Pages
  • Global
From
From
Endometriosis - Pipeline Review, H2 2020 - Product Thumbnail Image

Endometriosis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 156 Pages
  • Global
From
Loading Indicator

The Endometriosis Drug market is a subset of the Immune Disorders Drugs market. Endometriosis is a condition in which the tissue that normally lines the uterus grows outside of the uterus, causing pain and other symptoms. Endometriosis drugs are used to treat the symptoms of endometriosis, such as pain, heavy menstrual bleeding, and infertility. These drugs can be divided into two categories: hormonal therapies and non-hormonal therapies. Hormonal therapies include oral contraceptives, progestins, and gonadotropin-releasing hormone agonists. Non-hormonal therapies include non-steroidal anti-inflammatory drugs, danazol, and GnRH antagonists. Some companies in the Endometriosis Drug market include AbbVie, Allergan, Bayer, Merck, and Pfizer. Show Less Read more